Morgans Analyst Iain Wilkie talks to CEO of ASX listed regenerative medicine and stem-cell player Regeneus (ASX:RGS) on what the company does and a number of potential catalysts which lie ahead.

Under the microscope: Imagion Biosystems (ASX:IBX) - Robert Proulx, Chief Executive Officer

A series of podcasts that include interviews with executives from ASX-listed companies and updates on the healthcare sector.